Also known as: Alfuzosin hydrochloride

Therapeutic indications

Alfuzosin is indicated for:

Benign prostatic hypertrophy (BPH)

Population group: men, only adults (18 years old or older)

Treatment of the functional symptoms of benign prostatic hypertrophy (BPH).

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Alfuzosin is contraindicated in the following cases:

Orthostatic hypotension

Orthostatic hypotension

Alpha-1 receptor blockers

Selective α1-adrenergic receptor antagonists

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines